This document is an editorial from the International Journal of Molecular Sciences that discusses recent advancements in cancer treatment. The editorial highlights various innovative approaches, such as nanomedicines, combined therapy, drug repurposing, genomics, and personalized therapy, that target the ...
Introduction Recurrent or primary advanced metastatic cervical cancer (R/M CC) has a poor prognosis with a 5-year-survival rate of 16.5%, demanding novel a... I Vergote,I Ray-Coquard,D Lorusso,... - 《Expert Opinion on Investigational Drugs》 被引量: 0发表: 2023年 Antibody drug conjugat...
It is the first time any drug has been approved to treat certain patients with metastatic breast cancer who have a "BRCA" gene mutation, the FDA said on Friday. Patients are selected for treatment with Lynparza based on an FDA-approved genetic test. "This class of drugs has been used to...
One of the first patients to be given the treatment is still inremission(缓解,减轻)after two years. Lead researcher Dr Chris Lord said: "This new class of drugs could potentially make a big difference for many thousands of cancer patients, including some with very limited treatment options." ...
Further studies with these new drugs utilized in combination chemo therapeutic regimens are needed to define the role of these agents in the treatment of patients with SCLC.doi:10.1016/S0169-5002(10)80018-2DavidS.EttingerLung CancerEttinger DS. New drugs for treating small cell lung cancer. ...
Lead researcher Dr Chris Lord said: "This new class of drugs could potentially make a big difference for many thousands of cancer patients, including some with very limited treatment options." 4tumour 5tumours 肿瘤( tumour的名词复数 )
molecular mechanism of DKD, there are more and more new drugs based on this, such as new hypoglycemic drugs sodium-glucose cotransporter 2 (SGLT2) inhibitors, glucagon-like peptide-1 (GLP-1) inhibitors, and dipeptidyl peptidase-4 (DPP-4) inhibitors with good efficacy in clinical treatment. Be...
The country will step up efforts to ensure more early diagnosis and treatment of cancer, and offer preferential value added tax policies for drugs for treatment of rare diseases.
SYDNEY, Dec. 7 (Xinhua) -- Australian researchers on Friday said they have successfully combined two cancer drugs, offering a breakthrough in the treatment of women with metastatic breast cancer. The move, touted as the first of its kind, involved joining Venetoclax, a drug that has shown pr...
Targeted therapy drugs work in a few different ways. They may turn off the process in cancer cells that causes them to grow and spread, making cancer cells die on their own or kill cancer cells directly. People with the same type of cancer may have different targets in their cancer cells...